ONEILL ALISON 4
4 · Surface Oncology, Inc. · Filed Jan 14, 2022
Insider Transaction Report
Form 4
ONEILL ALISON
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2021-07-21$6.10/sh−14,809$90,335→ 30,191 total - Award
Common Stock
2020-03-01+45,000→ 45,000 total
Footnotes (2)
- [F1]The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in full on the date 18 months after January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such date.
- [F2]Amount reported represents the number of shares sold by the reporting person to cover the tax withholding obligations in connection with the vesting of restricted stock units.